Philips and Ibex Medical Analytics team to accelerate adoption of AI-powered digital pathology April 8, 2021 Philips and Ibex Medical Analytics cooperate to globally commercialize clinically proven, AI-powered digital pathology solutions Combination of Philips’ digital pathology solutions and Ibex’s AI-powered Galen platform has improved reporting efficiency by 27%, driven 37% productivity gains, and improved consistency and accuracy to enhance diagnostic confidence Collaboration furthers Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis Amsterdam, The Netherlands and Tel Aviv, Israel – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, today announced a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide. The combination of Philips digital pathology solution (